Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NephroGenex Inc (NASDAQ:NRX)

0.461
Delayed Data
As of 3:59pm ET
 -0.049 / -9.61%
Today’s Change
0.34
Today|||52-Week Range
8.90
-71.19%
Year-to-Date
No recent news for NephroGenex Inc.

Today’s Trading

Previous close0.51
Today’s open0.51
Day’s range0.44 - 0.52
Volume265,092
Average volume (3 months)218,077
Market cap$6.6M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-6.51%
Earnings growth (this year)+86.90%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.59

Competitors

 Today’s
change
Today’s
% change
DITAMCON Distributing C...-0.10-0.11%
CBAYCymaBay Therapeutics...-0.10-3.69%
BIOSBioScrip Inc-0.07-2.58%
AGXArgan Inc-0.26-0.75%
Data as of 4:02pm ET, 04/29/2016

Financials

Next reporting dateMay 11, 2016
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$22.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Secretary &
Treasurer
John P. Hamill
Vice President-
Clinical Operations
Pepper Landson
Corporate headquarters
Raleigh, North Carolina

Forecasts

Partner Offers

Search for Jobs